Stocktoria
QUAKER CHEMICAL CORP KWR
QUAKER CHEMICAL CORP financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.9B | $1.8B | $2.0B | $1.9B | $1.8B | $1.4B | $1.1B | $867.5M | $820.1M | $746.7M |
| Gross profit | $679.4M | $686.0M | $705.6M | $612.7M | $594.6M | $513.4M | $392.1M | $312.3M | $291.5M | — |
| R&D expense | $60.7M | $57.3M | $50.3M | $46.0M | $44.9M | $40.0M | $32.1M | $24.5M | $23.9M | $22.5M |
| SG&A expense | $502.4M | $484.8M | $483.6M | $464.2M | $418.9M | $380.8M | $283.8M | $207.9M | $198.8M | $193.7M |
| Operating income | $53.0M | $194.7M | $214.5M | $52.3M | $150.5M | $59.4M | $46.1M | $87.8M | $62.7M | $85.4M |
| Interest expense | — | — | $50.7M | $32.6M | $22.3M | $26.6M | $17.0M | $4.0M | $1.4M | $2.9M |
| Income tax | $24.6M | $49.3M | $55.6M | $24.9M | $34.9M | -$5.3M | $2.1M | $25.1M | $41.7M | $23.2M |
| Net income | -$2.5M | $116.6M | $112.7M | -$15.9M | $121.4M | $39.7M | $31.6M | $59.5M | $20.3M | $61.4M |
| EPS (diluted) | $-0.14 | $6.51 | $6.26 | $-0.89 | $6.77 | $2.22 | $2.08 | $4.45 | $1.52 | $4.63 |
| Operating cash flow | $136.5M | $204.6M | $279.0M | $41.8M | $48.9M | $178.4M | $82.4M | $78.8M | $64.8M | $73.8M |
| Free cash flow | $80.6M | $162.8M | $240.2M | $13.3M | $27.5M | $160.5M | $66.8M | $65.9M | $53.9M | $63.8M |
| Cash & equivalents | $179.8M | $188.9M | $194.5M | $181.0M | $165.2M | $181.8M | $123.5M | $104.1M | $89.9M | $88.8M |
| Inventory | $265.8M | $227.5M | $233.9M | $284.8M | $264.5M | $187.8M | $174.9M | $94.1M | $87.2M | $77.1M |
| Total assets | $2.8B | $2.6B | $2.7B | $2.8B | $3.0B | $2.9B | $2.9B | $709.7M | $722.1M | $692.0M |
| Total liabilities | $1.4B | $1.3B | $1.3B | $1.5B | $1.6B | $1.6B | $1.6B | $273.3M | $312.5M | $279.4M |
| Shareholders' equity | $1.4B | $1.4B | $1.4B | $1.3B | $1.4B | $1.3B | $1.2B | $436.4M | $409.6M | $412.6M |
Growth · year-over-year · Revenue CAGR 10.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +2.7% | -5.8% | +0.5% | +10.4% | +24.2% | +25.1% | +30.7% | +5.8% | +9.8% | +1.2% |
| Net income growth | -102.1% | +3.5% | — | -113.1% | +206.0% | +25.4% | -46.8% | +193.3% | -67.0% | +20.0% |
| EPS growth | -102.2% | +4.0% | — | -113.1% | +205.0% | +6.7% | -53.3% | +192.8% | -67.2% | +20.6% |
| Free cash flow growth | -50.5% | -32.2% | +1712.3% | -51.8% | -82.9% | +140.1% | +1.4% | +22.3% | -15.5% | +2.2% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.